These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1375012)

  • 41. Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
    Schröder CP; de Vries EG; Mulder NH; Willemse PH; Sleijfer DT; Hospers GA; van der Graaf WT
    J Antimicrob Chemother; 1999 May; 43(5):741-3. PubMed ID: 10382902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated arthralgia associated with granulocyte colony stimulating factor administration.
    Tsukadaira A; Okubo Y; Takashi S; Kobayashi H; Kubo K
    Ann Rheum Dis; 2002 Sep; 61(9):849-50. PubMed ID: 12176817
    [No Abstract]   [Full Text] [Related]  

  • 43. [A brief report on effect of rhG-CSF in treating leukopenia after radio-and chemo-therapy of patients with breast cancer].
    Wang TJ; Liu LL; Cheng GH; Liu XL; Qu YQ; Wu ZF; Zhang CF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):381-2. PubMed ID: 15228673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study.
    Sparano JA; Hu P; Rao RM; Falkson CI; Wolff AC; Wood WC
    J Clin Oncol; 1999 Dec; 17(12):3828-34. PubMed ID: 10577856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.
    Ozlem C; Deram B; Mustafa S; Koray T; Cuyan D; Ertugrul T
    Intern Med; 2011; 50(18):1973-6. PubMed ID: 21921379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy].
    Sanz Ortiz J; Llamazares A; López-Vega JM
    Med Clin (Barc); 1993 Sep; 101(7):276. PubMed ID: 7538188
    [No Abstract]   [Full Text] [Related]  

  • 48. High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide.
    Soong D; Haj R; Leung MG; Myers R; Higgins B; Myers J; Rajagopal S
    J Clin Oncol; 2009 Sep; 27(26):e101-2. PubMed ID: 19652050
    [No Abstract]   [Full Text] [Related]  

  • 49. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides.
    Johnson ML; Grimwood RE
    Arch Dermatol; 1994 Jan; 130(1):77-81. PubMed ID: 7506900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sweet's syndrome associated with granulocyte colony-stimulating factor.
    Jain KK
    Cutis; 1996 Feb; 57(2):107-10. PubMed ID: 8646854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of granulocyte colony-stimulating factor on cardiac function in patients with acute myocardial infarction and leukopenia after revascularization.
    Guo SZ; Wang NF; Zhou L; Ye XH; Pan H; Tong GX; Yang JM; Xu J
    Chin Med J (Engl); 2010 Jul; 123(14):1827-32. PubMed ID: 20819563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cancer of the breast in young women: should chemotherapy be intensified?].
    Piccart MJ
    Pathol Biol (Paris); 1992 Nov; 39(9):843-4. PubMed ID: 1371604
    [No Abstract]   [Full Text] [Related]  

  • 53. Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
    Kümmel S; Thomas A; Paepke S; Schwarz M; Heinrich G; Wetzel A; Elling D; Kohls A; Lichtenegger W; Blohmer JU
    Acta Oncol; 2005; 44(3):248-54. PubMed ID: 16076697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer.
    Sato K; Tsuchiya S; Minato K; Sunaga N; Ishihara SI; Makimoto T; Naruse I; Hoshino H; Watanabe S; Saitoh R; Mori M
    Oncol Rep; 2000; 7(5):1135-9. PubMed ID: 10948352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
    Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R
    Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reply to E.J. Moylan et al.
    Swain SM; Tang G; Geyer CE
    J Clin Oncol; 2014 Feb; 32(6):606-7. PubMed ID: 24419136
    [No Abstract]   [Full Text] [Related]  

  • 57. Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
    Wasserheit C; Frazein A; Oratz R; Sorich J; Downey A; Hochster H; Chachoua A; Wernz J; Zeleniuch-Jacquotte A; Blum R; Speyer J
    J Clin Oncol; 1996 Jul; 14(7):1993-9. PubMed ID: 8683229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 59. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
    Lei KI; Leung WT; Johnson PJ
    Br J Cancer; 1994 Nov; 70(5):1009-13. PubMed ID: 7524599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.